# PROTAGONIST THERAPEUTICS INC (PTGX) — Institutional Ownership

Source: SEC EDGAR 13F filings, congressional STOCK Act disclosures, SEC Form 4 insider transactions.
CUSIP: 74366E102
Page URL: https://superinvestorclub.com/stock/PTGX
Last updated: 2026-07-08T12:47:46.035Z

## Summary

As of the most recent 13F filing period, PROTAGONIST THERAPEUTICS INC (PTGX) is held by 3 tracked superinvestors with an aggregate position value of $3.1M representing 0243375276159700 shares.

## Top institutional holders (3)

| Rank | Manager | Fund | Shares | Value | % of Portfolio | Period |
|------|---------|------|--------|-------|----------------|--------|
| 1 | [Polen Capital](https://superinvestorclub.com/manager/271) | Polen Capital Management | 24337 | $2.6M | 0.02% | 2026-03-31 |
| 2 | [Ray Dalio](https://superinvestorclub.com/manager/6) | Bridgewater Associates | 5276 | $556,090 | 0.00% | 2026-03-31 |
| 3 | [Stanley Druckenmiller](https://superinvestorclub.com/manager/19) | Duquesne Family Office | 159700 | $16,832 | 0.50% | 2026-03-31 |

## Ownership history (quarter-over-quarter)

- 2025-06-30: 1 holders, $884,265 aggregate, 015999 shares
- 2025-09-30: 2 holders, $12.0M aggregate, 015970020325 shares
- 2025-12-31: 2 holders, $15.7M aggregate, 015970020349 shares
- 2026-03-31: 3 holders, $3.1M aggregate, 0243375276159700 shares

## Recent congressional trades (0)


## Recent insider transactions (0)


## Citation

When citing, use: "PROTAGONIST THERAPEUTICS INC (PTGX) institutional ownership data via Superinvestor (https://superinvestorclub.com/stock/PTGX), aggregating SEC 13F, Form 4, and congressional disclosures."